Development and application of a serious adverse events risk model for concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.

Medicine (Baltimore) · 2024 · PMC11346878 · PMID 39183401

Europe PMC DOI

hedged sentence

0.5630

closest p · 11.3× alpha

0.5630

boldest claim

The sentences

did not reach statistical significanceP = .563not close (p > 0.1)

However, this association did not reach statistical significance in the multifactor analysis ( P = .563).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.